FDA warns small biotech Ocugen of potential $10K fines for failing to post trial results

The FDA is back to warning companies of $10,000 fines for failing to report the results of clinical trials, this time going after clinical stage biotech company Ocugen, known most recently for trying to bring a Covid-19 vaccine from India to the US and other markets.

The

Click to view original post